Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
USRE38628 | ALLERGAN | Pharmaceutical compositions |
Aug, 2012
(11 years ago) |
Market Authorisation Date: 08 December, 1999
Treatment: A method of treatment of a condition involving an antibody antigen reaction
Dosage: SOLUTION/DROPS;OPHTHALMIC